IMM 20.3% 35.5¢ immutep limited

Ann: Transcript of CAN-003 data conference call , page-14

  1. 15 Posts.
    re: Ann: Transcript of CAN-003 data conferenc... SBLIM,

    One would assume that Prima should have forecasted figures on the size of the world 2nd remission market, an update on the "COMPANIES VIEW" of the forecasted market scope for 2nd remission patients would be a welcome addition to the current flow of information.

    If the figures below can be taken at face value,
    the math can be done roughly on these two countries for examples sake ON A PER YEAR BASIS.

    BACKGROUND: About 22,000 American women were expected to be diagnosed with ovarian cancer in 2013. Around 14,000 were expected to die. According to Mercy Medical Center
    Source: Mercy Medical Center)

    http://www.newschannel5.com/story/25682858/heating-up-ovarian-cancer

    BACKGROUND: There is no early detection test for ovarian cancer and the Pap test does not detect the disease.
    Each year in Australia around 1400 women are diagnosed with ovarian cancer and more than 1000 will die from the disease.

    http://www.ovariancancer.net.au/awareness/


    Best Regards to all,
    aussieoscar
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.060(20.3%)
Mkt cap ! $515.6M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $6.427M 18.03M

Buyers (Bids)

No. Vol. Price($)
1 50000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 133736 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.